Rhumbline Advisers Raises Stock Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)
Rhumbline Advisers raised its stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 5.3% during the fourth quarter, Holdings Channel reports. The firm owned 73,431 shares of the company’s stock after buying an additional 3,675 shares during the quarter. Rhumbline Advisers’ holdings in 4D Molecular Therapeutics were worth $409,000 at the […]
Rhumbline Advisers raised its stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 5.3% during the fourth quarter, Holdings Channel reports. The firm owned 73,431 shares of the company’s stock after buying an additional 3,675 shares during the quarter. Rhumbline Advisers’ holdings in 4D Molecular Therapeutics were worth $409,000 at the […]
